Sign Up to like & get
recommendations!
0
Published in 2019 at "BMJ Case Reports"
DOI: 10.1136/bcr-2019-231185
Abstract: Eluxadoline is a novel medication that was approved in the USA in 2015 for the treatment of diarrhoea-predominant irritable bowel syndrome. Due to its unique mechanism of action as both an opioid agonist and antagonist,…
read more here.
Keywords:
induced pancreatitis;
prior cholecystectomy;
adult man;
eluxadoline induced ... See more keywords